Company Filing History:
2 out of 950 
1 out of 168 
Years Active: 2016-2019
Title: Kimitaka Nakama: Innovator in Pharmaceutical Chemistry
Introduction
Kimitaka Nakama is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, Nakama's work focuses on innovative solutions for medical challenges.
Latest Patents
Nakama's latest patents include the development of aminopyrazole derivatives. The objective of this invention is to provide low-molecular-weight compounds that can inhibit Src family kinases. The compounds are represented by a general formula and include pharmacologically acceptable salts. Additionally, he has developed an orally available viridiofungin derivative possessing anti-HCV activity. This compound is designed to be useful as an orally available anti-HCV agent and is represented by a specific formula, showcasing its potential as a medicine.
Career Highlights
Throughout his career, Kimitaka Nakama has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Chugai Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Nakama has collaborated with esteemed colleagues in his field, including Hirosato Ebiike and Toshihiro Aoki. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Kimitaka Nakama is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to addressing significant medical needs through scientific advancement.